Market Introduction
APAC consists of five major countries namely China, Japan, India, Australia, and South Korea. The market is also evaluated for the rest of countries in APAC. The market is driven by the factors such as increasing incidences of chronic diseases such as diabetes, kidney disorder and liver diseases, growing strategic developments in urinalysis market, and growing development for healthcare facilities that demand advanced urinalysis analyzers for accurate and precise diagnosis. Moreover, growing geriatric population in the region, and increasing number of diagnostic laboratories in this region will support the market growth during the forecast period.
The COVID-19 pandemic affected most programs in APAC, but to varying degrees. Medical device manufacturers and suppliers are shifting their focus on supplying essentials and medical devices related to the management of COVID-19. The shift in focus toward pandemic has disrupted the spectrum of kidney and renal care, including delayed diagnoses and treatment, and disrupted clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients receive essential care while minimizing exposure to SARS-CoV-2 infection. Diagnostic testing service providers are coordinating with healthcare authorities to manage testing services residues, prioritize testing services, and use modern technology to overcome potential barriers. The increased adoption of at-home settings for urinalysis for the diagnosis of diseases such as UTIs, and other renal and kidney diseases tests also helped fill the gaps in screening. The transport restrictions imposed by various countries have had a major influence on international trade and commerce. India, too, has suffered owing to unexpected economic disruptions caused by interim restrictions on public activities and regional lockdowns. Asia’s value chains have closely integrated the economies of China, Japan, South Korea, Hong Kong, and other Asian countries. Such dense and extremely coordinated value chains enable massive economies of scale in manufacturing.
Market Overview and Dynamics
The urinalysis market in APAC is expected to grow from US$ 917.20 million in 2021 to US$ 1,411.47 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The rest of the APAC region includes Thailand, New Zealand, Singapore, Myanmar, Vietnam, and Hong Kong. The countries are developing fastest in terms of healthcare infrastructure that are involved in the rapid technological developments in diagnostic procedures and increasing trend of medical tourism in these countries due to cost effective medical procedures will support the development of urinalysis market. For instance, Sysmex Thailand a leading provider of automated urinalysis solutions, has received ISO 9001:2015 certification to sale, distribute, and install clinical diagnostic equipment in laboratories, hospitals, and healthcare organizations. Moreover, according to report published in MDPI journal of pharmaceutics in 2020, Malaysia has been ranked as the highest diabetes cases recorded in Asia, with around 3.6 million patients. By 2025, it is expected that around seven million adults will suffer from diabetes. Therefore, increasing screening of diabetes and other non-communicable as well as infectious diseases might provide significant growth opportunities for urinalysis market in rest of the APAC region during the forecast period.
Key Market Segments
APAC urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the APAC urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The APAC urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the APAC urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The APAC urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the APAC urinalysis market is segmented into Australia, China, India, Japan, South Korea, and rest of APAC. China held the largest market share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the urinalysis market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.
Reasons to buy report
APAC Urinalysis Market Segmentation
APAC Urinalysis Market - By Product
APAC Urinalysis Market - By Test Type
APAC Urinalysis Market - By Application
APAC Urinalysis Market - By End User
APAC Urinalysis Market - By Country
APAC Urinalysis Market - Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 917.20 Million |
| Market Size by 2028 | US$ 1,411.47 Million |
| CAGR (2021 - 2028) | 6.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Urinalysis Market is valued at US$ 917.20 Million in 2021, it is projected to reach US$ 1,411.47 Million by 2028.
As per our report Asia Pacific Urinalysis Market, the market size is valued at US$ 917.20 Million in 2021, projecting it to reach US$ 1,411.47 Million by 2028. This translates to a CAGR of approximately 6.4% during the forecast period.
The Asia Pacific Urinalysis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Urinalysis Market report:
The Asia Pacific Urinalysis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Urinalysis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Urinalysis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Urinalysis Market
